A. Kadari et al., CELL-DEATH OF ADULT PYRAMIDAL CA1 NEURONS AFTER INTRAVENTRICULAR-INJECTION OF A NOVEL PEPTIDE DERIVED FROM TRKA, Journal of neuroscience research, 50(3), 1997, pp. 402-412
Members of the nerve growth factor (NGF) family of neurotrophins bind
to the second leucine-rich motif (LRM2) within the extracellular domai
ns of their respective receptors (trkA, trkB, trkC). Small LRM2 peptid
es have been recently demonstrated to selectively bind the neurotrophi
ns revealing similar complex binding characteristics as full-length re
ceptors, We extend our recent findings, showing that the peptides (A a
nd C) do not block nerve fiber outgrowth through high affinity trk rec
eptors in a ganglia bioassay, Since the highest concentration of neuro
trophins [NGF brain-derived neurotrophic factor (BDNF), neurotrophin-3
(NT-3)lj is found in the hippocampus, the peptides were injected into
the 3rd ventricle of anesthetized adult rats, The (NGF binding) LRM2-
A peptide, but not the (BDNF binding) LRM2-B or the (NT-3 binding) LRM
2-C peptides, caused severe apoptotic neurodegeneration of hippocampal
pyramidal CA1 neurons as revealed by; cresyl violet staining and the
TUNEL reaction, The degeneration was protected by intrahippocampal inj
ection of NGF-beta and by the non-N-methyl-D-aspartate (NMDA) antagoni
st CNQX (6-cyano-7-nitroquinoxaline-2,3-dione), indicating a glutamate
rgic mechanism, In situ hybridization revealed that pyramidal CA1 neur
ons did not express trkA and p75 receptor mRNA in sham and LRM2-A-lesi
oned animals, If is concluded that the LRM2-A peptide represents a nov
el peptide with properties to induce apoptotic cell death of pyramidal
CA1 neurons and may be useful as an experimental agent. (C) 1997 Wile
y-Liss, Inc.